Sonoma Pharmaceuticals, Inc. (240) | Business Finance (4)

Browse by Subcategory

Recent Contracts

SONOMA PHARMACEUTICALS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM AND STOCK OWNERSHIP GUIDELINES Revised by the Board of Directors on December29, 2022 (Filed With SEC on December 30, 2022)
Asset Purchase Agreement dated February 21, 2020, between Sonoma Pharmaceuticals, Inc. and Microsafe Group, DMCC (Filed With SEC on February 27, 2020)
Form of Placement Agent Warrant granted to Dawson James Securities, Inc. in connection with the November 2019 public offering (Filed With SEC on November 29, 2019)
Asset Purchase Agreement dated May 14, 2019, between Sonoma Pharmaceuticals, Inc. and Petagon, Ltd (Filed With SEC on May 22, 2019)